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1. Introduction of substrate analogs [1,2]. The analogous nitrile, the 
neurotoxin pcyano-Galanine, isa potent but freely 
The discovery by Abeles and Walsh that ycystathio- reversible inhibitor of ycystathionase [3]. However, 
nase and mechanistically similar enzymes are inacti- we have found that @cyano-Lalanine isa suicide inac- 
vated by the antibiotic pethynyl-L-alanine provided tivator of porcine heart alanine aminotransferase, a 
an elegant example of the phenomenon of suicide pyridoxal enzyme which shares with ycystathionase 
inactivation i  which enzymes catalyze their own inac- the ability to abstract protons from both the /3- and 
tivation upon unmasking latent reactive functionalities a-positions of its substrates (flg.1) [4,5]. 
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Fig.1. The rcystathionase reaction (A) and one putative suicide reaction of pcyano-Lalanine (B). The enzyme ordinarily abstracts 
a @proton from cystathionine or homoserine in a p,~elimination reaction that ultimately yields aoxobutanoate. Enzymatic 
removal of a p-proton from cyanoalanine may generate areactive ketenimine which transiently imino acylates an activetite nucle- 
ophilic group. The ketenimine is much more electrophilic than the ordinary olefiic intermediate. This scheme is analogous to 
that proposed in [l] for the suicide reaction of pethynyl-L&nine (propargylglycine) with ~+zystathionase. Any covalent modifi- 
cation of the active site of the rat liver ycystathionase by cyanoalanine must be labile since the potent inhibition by cyanoalanine 
is rapidly reversible. However, the inhrbition of a p-protonabstracting alanine aminotransferase by cyanoalanine is not rapidly 
reversible (trla =, 30 mitt) [S]. 
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Here, we report that ycystathionase is subject to 
suicide inactivation by fl-trifluoromethyl-D,Lalanine 
(Z-amino4,4,4-trifluorobutanoic acid, fig2A) and by 
fl-trifluorovinyl-D,L-alanine (2-amino4,5,5-trifluoro- 
4-pentenoic acid, fig2B). The inactivation of this 
enzyme catalyzing fl,yelimination reactions by a com- 
pound multiply halogenated at the y-carbon supports 
the view inferred from studies of /3-polyhalogenated 
amines [6,7] that this strategy of multiple halogen- 
ation, at the appropriate carbon, will prove generally 
applicable to the design of mechanism-based enzyme 
inactivators. 
2. Materials and methods 
Crystalline rcystathionase was isolated from the 
livers of adult male Sprague-Dawley rats [ 81. Taking 
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the molecular turnover number at saturating D,L- 
homoserine was 32 s-l at 25°C and pH 7.4 in a solu- 
tion containing 0.1 mM pyridoxal 5’-phosphate, 
5 .O mM mercaptoethanol, 1 .O mM EDTAand 100 mM 
potassium 4-(2-hydroxyethyl)1 -piperazineethanesul- 
fonate (Hepes). &Trifluoromethyl-D,L-alanine [9], 
P-trifluorovmyl-D,L-alanine [lo], fl-trichloromethyl- 
L-alanine [ 111, fldichloromethyl-Lalanine [ II], and 
P-acetyl-D,L-alanine [ 12 J were synthesized by pub- 
lished procedures. 
We found that @chloroalanine serves as a substrate 
of the cystathionase. Since a-oxobutanoate (fig.lA) is 
a poor substrate of lactate dehydrogenase, in some of 
our experiments in which the activity of cystathionase 
was followed by the coupling of a cystathionasecata- 
lyzed reaction to a dehydrogenation, fl-chloroalanine 
was employed as a pyruvate-generating substrate of 
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Fig.2. Probable suicide reaction mechanismsof p-trifluoromethyl-L-alanine (A) and of p-trifhtorovinyl-L-alanine (B). After p-proton 
abstraction, the former compound may acylate rcystathionase via either a fluorineactivated olefin or an acyl fluoride. The latter 
compound may trap the enzyme via either an alJene or a fluorineactivated olefin. Tautomeric structures are also plausible, and 
the acarbon of the latter compound is potentiahy reactive. 
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cystathionase. At 25°C and pH 7.4 in a solution con- 
taining 0.1 mM pyridoxal5’-phosphate, 5.0 mM mer- 
captoethanol, 1 .O mM EDTA, 0.2 mM NADH, excess 
lactate dehydrogenase and 100 mM Hepes, the V,,, 
value for flchloro-D,L-alanine is 1.7-fold greater than 
that of D,L-homoserine whereas the Km-value (10 mM) 
is 1/3rd that (33 mM) observed for D,L-homoserine. 
3. Results 
Progressive inactivation of ycystathionase by y- 
fluorinated amino acids is sensitively monitored by 
means of continuous recordings of NADH absorbance 
following the addition of cystathionase to dehydro- 
genasecoupled assay solutions containing the suicide 
inactivator and a sub-saturating level of homoserine 
or ~chloroalanine (fig.3). We have confirmed the irre- 
versibility of the inactivation by these fluoro com- 
pounds in experiments in which the cystathionase was 
incubated with the inactivators at 25°C and pH 7.4. 
Progressive inactivation is seen when small aliquots 
(10 $1) of the incubated solutions are withdrawn at 
intervals and then diluted 1 OO-fold into assay solutions 
containing saturating (200 mM) levels of D,Lhomo- 
serine. Inactivation is also not reversed when the inac- 
tivated enzyme is washed by dialysis against 10 mM 
Hepes buffer containing 0.1 mM pyridoxal S’-phos- 
phate at pH 7.4 and4” C for 48 h. The enzyme treated 
with either no amino acid or, interestingly, with @- 
cyano-L-alanine retains full activity during dialysis. 
We have also examined j3-trichloromethyl-L-alanine 
and P-dichloromethyl-Lalanine for activity as suicide 
substrates. The ydichloro compound, armentomycin, 
is a toxic antibiotic elaborated by a strain of Strepto- 
myces armentosus [ 131. Upon incubation of ycysta- 
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Fig.3. Timedependent inhibition of rcystathionase by r-fluoro compounds. The production of pyruvate from pchloroalanine is 
followed by the coupling of that cystathionase-catalyzed reaction to the lactate dehydrogenase r action. The decrease in absorbance 
of NADH is given as a function of time. The reaction solutions initially contain either 9.6 mM p-trifluoromethyl-D,Lalanine or 
else 120 mM p-trifluorovinyl-Lalanine as well as 6.0 mM pchloro-D,Lalanine, 5.0 mM mercaptoethanol, 1.O mM EDTA, 0.2 mM 
NADH, 0.1 mM pyridoxal 5’-phosphate, lactate dehydrogenase (70 pg/ml), and 100 mM Hepes/KOH at pH 7.4 and 25°C. The 
reactions are initiated by the addition of cystathionase (4.6 or 2.3 rg/ml). The absorbance is read against a slight non-enzymatic 
rate of pyruvate production from pthloro-D,Lalanine. The first-order exponential decay of the velocity is secondary to inactiva- 
tion of the cystathionase rather than to accumulation of an inhibitory product because successive additions of enzyme produce 
identical bursts of pyruvate. 
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Fig.4. Observed first-order rate constants for the inactivation of r-cystathionase by y-fluoro a-amino acids at pH 7.4 and 25°C. 
These data were obtained from experiments uch as those shown in fig.3. The reaction mixtures contained either 5 .O mM (0) or 
50 mM mercaptoethanol (0). The inhibitor concentration varied as indicated, and the enzyine varied from 140-l .l Mgcglml. Because 
of the low solubility of the fluoro compounds and their low affinity for the enzyme, it was not possible to accurately measure 
their kinetic binding constants nor to extrapolate to a maximal rate of inactivation. However, the insensitivity of the rate of inac- 
tivation toward the nucleophilic agent mercaptoethanol indicates that an electrophilic species which inactivates the enzyme would 
have to be generated within a space sheltered from nucleophiles in free solution (as in a Michaelis complex at the active site). 
thionase with the chloro compounds (25 mM) in 
100 mM potassium phosphate buffer (pH 7.4) also 
containing0 .l mM pyridoxal 5’-phosphate at 25°C for 
3 .O h, aliquots of the solution containing the trichloro 
compound were fully active, and the enzyme treated 
with armentomycin retained 85% of the initial activity. 
Furthermore, the porcine heart alanine aminotrans- 
ferase which is subject to inactivation by fl-ethynyl-L- 
alanine [2] and by fl-cyano-Lalanine [5] is not inac- 
tivated by the y-fluoro nor ychloro compounds. No 
inactivation is detected after its incubation with the 
compounds (25 mM) for 2.0 h at 25°C in 100 mM 
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potassium phosphate buffer (pH 7.4) also containing 
10 mM craxoglutarate. The y-halo compounds were 
not effective competitive inhibitors of either enzyme, 
the Ki-values all exceeding 25 mM. 
4. Discussion 
Since inactivation of y-cystathionase by&trifluoro- 
methyl-D,L-alanine is irreversible, the potent but 
reversible inhibition of the enzyme by fl-cyano-L-ala- 
nine may not involve an acylation reaction such as 
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that depicted in fig.lB. Alternatively, removal of the 
&proton from flcyano-L-alanine may result in tauto- 
merization to a cyano enamine rather than to the 
ketenimine shown. Such an enamine may be meta- 
stable in view of the stability of ketoenamines [5,14]. 
However, theKi-value of/$acetyl-D,L-alanine, 50 mM, 
is orders of magnitude greater than that of @yano-L- 
alanine, 0.1 PM [3]. 
P-Polyhalogenated amines such as Pfidichloro- and 
fl.j@trifluoroalanine are suicide substrates for a wide 
range of pyridoxal enzymes, including ycystathionase 
[6,7]. In general, y-halogenated amines ought to prove 
more selective than /I-halogenated compounds as inac- 
tivators of pyridoxal 5’-phosphate-dependent and 
similar enzymes since all pyridoxal enzymes generate 
ocarbanionic species whereas only a small subset also 
abstract P-protons from their substrates. 
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